
    
      This is a special drug use surveillance on long-term use of pioglitazone/glimepiride
      combination tablets (Sonias Combination Tablets LD) designed to investigate the frequency of
      adverse drug reactions in patients with type 2 diabetes mellitus who respond poorly to
      pioglitazone hydrochloride monotherapy (pioglitazone at 15 mg/day).

      The usual adult dosage is one tablet (15 mg/1 mg of pioglitazone/glimepiride) administered
      orally once daily before or after breakfast.
    
  